 | Monter d'un niveau |
Buschmann, M. D., Merzouki, A., Lavertu, M., Thibault, M., Jean, M., & Darras, V. (2013). Chitosans for delivery of nucleic acids. Advanced Drug Delivery Reviews, 65(9), 1234-1270. Lien externe
Merzouki, A., Buschmann, M. D., Jean, M., Young, R. S., Liao, S., Gal, S., Li, Z., & Slilaty, S. N. (2012). Adva-27a, a Novel Podophyllotoxin Derivative Found to Be Effective Against Multidrug Resistant Human Cancer Cells. Anticancer Research, 32(10), 4423-4432. Lien externe
Jean, M., Alameh, M., De Jesus, D., Thibault, M., Lavertu, M., Darras, V., Nelea, M., Buschmann, M. D., & Merzouki, A. (2012). Chitosan-Based Therapeutic Nanoparticles for Combination Gene Therapy and Gene Silencing of in Vitro Cell Lines Relevant to Type 2 Diabetes. European Journal of Pharmaceutical Sciences, 45(1-2), 138-149. Lien externe
Merzouki, A., Alameh, M., DeJesus, D., Jean, M., Darras, V., Thibault, M., Lavertu, M., & Buschmann, M. D. (2012). Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. International Journal of Nanomedicine, 7, 1399-1414. Disponible
Alamech, M., Jean, M., DeJesus, D., Buschmann, M. D., & Merzouki, A. (2010). Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing. International Journal of Nanomedicine, 5, 473-481. Lien externe
Jean, M., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (mai 2014). Combining delivery of GLP-1 gene expressing plasmid and DPP-4 gene silencing siRNA using Chitosan-based nanoparticles for Type-2 Diabetes treatment [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Publié dans Molecular Therapy, 22(S1). Disponible
Jean, M., Derbali, R., DeJesus, D., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (mai 2014). Apolipoprotein B knock-down by Chitosan/ApoB-siRNA nanoparticles lowers plasma cholesterol in atherosclerosis mouse model [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Publié dans Molecular Therapy, 22(S1). Disponible
Jean, M., Behhammadi, M., Sidique, A., Jeandupeux, D., Merzouki, A., & Buschmann, M. D. (mai 2014). P-Glycoprotein knock-down by Chitosan/Mdr1-siRNA nanoparticles increases sensitivity to chemotherapeutics [Résumé]. 17th Annual Meeting of the American Society of Gene & Cell Therapy, Washington, DC (1 page). Publié dans Molecular Therapy, 22(S1). Disponible
